Clinical Trial Update: R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the Rituximab-based R-CMOP regimen in newly diagnosed diffuse large B-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-CMOP

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Diffuse Large B-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING